RY:NYE-Royal Bank Of Canada (USD)

EQUITY | Banks—Diversified | New York Stock Exchange

Last Closing

USD 81.52

Change

+0.12 (+0.15)%

Market Cap

USD 98.47B

Volume

0.49M

Analyst Target

USD 88.84
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Royal Bank of Canada is a financial services company which provides personal and commercial banking, wealth management services, insurance, corporate and investment banking and transaction processing services.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-02-19 )

Largest Industry Peers for Banks—Diversified

Symbol Name Price(Change) Market Cap
JPM-PC JPMorgan Chase & Co

-0.05 (-0.19%)

USD 345.65B
JPM-PD JPMorgan Chase & Co

+0.17 (+0.66%)

USD 339.98B
JPM JPMorgan Chase & Co

+3.66 (+4.04%)

USD 278.63B
BAC-PB Bank of America Corporation

+0.06 (+0.23%)

USD 260.57B
BAC-PK Bank of America Corporation

+0.03 (+0.12%)

USD 259.65B
BAC-PC Bank of America Corporation

+0.09 (+0.35%)

USD 257.04B
BAC-PL Bank of America Corporation

+17.57 (+1.35%)

USD 255.76B
BAC-PE Bank of America Corporation

+0.19 (+0.89%)

USD 254.42B
BML-PL Bank of America Corporation

+0.02 (+0.10%)

USD 246.79B
BML-PH Bank of America Corporation

+0.14 (+0.78%)

USD 244.19B

ETFs Containing RY

FLCA Franklin FTSE Canada ETF 8.78 % 0.09 %

N/A

USD 7.38M
D5BH:XETRA Xtrackers MSCI Canada UCI.. 8.04 % 0.00 %

+1.11 (+-0.13%)

USD 0.27B
EWC iShares MSCI Canada ETF 7.98 % 0.47 %

+0.48 (+-0.13%)

USD 2.42B
HCAD:LSE HSBC MSCI Canada UCITS ET.. 7.95 % 0.00 %

N/A

USD 0.03B
UIM9:F UBS ETF - MSCI Canada UCI.. 7.69 % 0.00 %

-0.33 (-0.13%)

N/A
UIM9:XETRA UBS ETF - MSCI Canada UCI.. 7.69 % 0.00 %

-0.09 (-0.13%)

N/A
UC87:LSE UBS ETF - MSCI Canada UCI.. 7.69 % 0.00 %

+69.00 (+-0.13%)

N/A
UB23:LSE UBS ETF - MSCI Canada UCI.. 7.69 % 0.00 %

+48.75 (+-0.13%)

N/A
XCAD:LSE Xtrackers MSCI Canada UCI.. 7.68 % 0.00 %

+1.56 (+-0.13%)

USD 0.27B
D5BH:F Xtrackers MSCI Canada UCI.. 7.68 % 0.00 %

-0.59 (-0.13%)

USD 0.27B
H4ZR:F HSBC MSCI Canada UCITS ET.. 7.65 % 0.00 %

-0.25 (-0.13%)

USD 0.03B
HCAN:PA HSBC MSCI Canada UCITS ET.. 7.65 % 0.00 %

-0.03 (-0.13%)

USD 0.03B
H4ZR:XETRA HSBC MSCI Canada UCITS ET.. 7.65 % 0.00 %

-0.04 (-0.13%)

USD 0.03B
HCAN:LSE HSBC MSCI Canada UCITS ET.. 7.65 % 0.00 %

N/A

USD 0.03B
SXR2:XETRA iShares VII PLC - iShares.. 7.64 % 0.00 %

-0.33 (-0.13%)

USD 0.68B
SXR2:F iShares VII PLC - iShares.. 7.64 % 0.00 %

-1.04 (-0.13%)

USD 0.68B
CSCA:LSE iShares VII PLC - iShares.. 7.64 % 0.00 %

-63.50 (-0.13%)

USD 0.68B
CCAU:LSE iShares VII PLC - iShares.. 7.64 % 0.00 %

-0.22 (-0.13%)

USD 0.68B
ZCAN SPDR Solactive Canada ETF 7.59 % 0.30 %

+0.76 (+-0.13%)

USD 0.02B
HEWC iShares Currency Hedged M.. 7.58 % 0.03 %

+0.54 (+-0.13%)

USD 0.05B
US1:PA Amundi Index Solutions - .. 3.60 % 0.00 %

+0.13 (+-0.13%)

USD 0.05B
HDAW Xtrackers MSCI All World .. 3.18 % 0.20 %

-0.21 (-0.13%)

USD 0.02B
IQDY FlexShares International .. 2.71 % 0.47 %

+0.21 (+-0.13%)

USD 0.02B
IQDF FlexShares International .. 2.65 % 0.47 %

+0.18 (+-0.13%)

USD 0.61B
IQDE FlexShares International .. 2.51 % 0.47 %

+0.21 (+-0.13%)

USD 0.07B
FGBL:PA First Trust Global Equity.. 2.43 % 0.00 %

-0.23 (-0.13%)

USD 0.02B
FGBL:LSE First Trust Global Equity.. 2.43 % 0.00 %

N/A

USD 0.02B
GINC:LSE First Trust Global Equity.. 2.43 % 0.00 %

N/A

USD 0.02B
AFRN:PA Amundi Index Solutions - .. 2.03 % 0.00 %

+0.06 (+-0.13%)

N/A
US3:PA Amundi Index Solutions - .. 1.88 % 0.00 %

+0.38 (+-0.13%)

USD 0.05B
IXG iShares Global Financials.. 1.74 % 0.46 %

+1.30 (+-0.13%)

USD 0.46B
XDWF:XETRA Xtrackers MSCI World Fina.. 1.74 % 0.00 %

-0.02 (-0.13%)

USD 0.25B
XDWF:F Xtrackers MSCI World Fina.. 1.74 % 0.00 %

-0.27 (-0.13%)

USD 0.25B
XDWF:LSE Xtrackers MSCI World Fina.. 1.74 % 0.00 %

-0.04 (-0.13%)

USD 0.25B
WFIN:LSE SPDR MSCI World Financial.. 1.72 % 0.00 %

N/A

USD 0.10B
VYMI Vanguard International Hi.. 1.14 % 0.32 %

+0.21 (+-0.13%)

USD 1.56B
IDLV Invesco S&P International.. 0.71 % 0.25 %

+0.30 (+-0.13%)

USD 0.78B
RAVI FlexShares Ready Access V.. 0.00 % 0.25 %

+0.25 (+-0.13%)

USD 0.32B
QCAN 0.00 % 0.30 %

N/A

N/A
TCC4:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

+0.65 (+-0.13%)

N/A
VNLA Janus Henderson Short Dur.. 0.00 % 0.35 %

-0.01 (-0.13%)

USD 1.33B
FRNE:XETRA Amundi ETF Floating Rate .. 0.00 % 0.00 %

+0.10 (+-0.13%)

USD 0.85B
IPF 0.00 % 0.40 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Banks—Diversified) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.93% 87% B+ 65% D
Dividend Return 1.00% 57% F 65% D
Total Return 3.93% 87% B+ 70% C-
Trailing 12 Months  
Capital Gain 5.77% 76% C 49% F
Dividend Return 4.72% 50% F 80% B-
Total Return 10.50% 76% C 53% F
Trailing 5 Years  
Capital Gain 31.93% 84% B 69% D+
Dividend Return 28.22% 89% B+ 85% B
Total Return 60.15% 84% B 76% C
Average Annual (5 Year Horizon)  
Capital Gain 8.85% 81% B- 73% C
Dividend Return 14.07% 86% B 80% B-
Total Return 5.23% 75% C 82% B-
Risk Return Profile  
Volatility (Standard Deviation) 14.03% 71% C- 53% F
Risk Adjusted Return 100.29% 90% A- 83% B
Market Capitalization 98.47B 37% F 98% A+

Key Financial Ratios

  Ratio vs. Industry/Classification (Banks—Diversified) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 12.90 13% F 69% D+
Price/Book Ratio 2.12 6% F 41% F
Price / Cash Flow Ratio -4.32 92% A- 89% B+
Price/Free Cash Flow Ratio 83.46 4% F 5% F
Management Effectiveness  
Return on Equity 15.74% 98% A+ 79% C+
Return on Invested Capital 3.55% 26% F 31% F
Return on Assets 0.93% 36% F 23% F
Debt to Equity Ratio 136.69% 53% F 25% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters then its peers, placing it in the top quartile.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector